The Liver Cancer Fusion Predictor makes liver cancer screening more convenient with at-home blood collection by a trained phlebotomist and a secure digital report.
Certain liver conditions and other health factors can increase the risk of hepatocellular carcinoma (HCC). If you have one or more of these risk factors, consider regular liver cancer screening and discuss your screening plan with your healthcare provider.
Chronic viral hepatitis is a leading cause of liver cancer globally. Hepatitis B can lead to HCC even without cirrhosis, while HCC risk in hepatitis C is particularly increased with advanced fibrosis or cirrhosis. If you have chronic hepatitis B or C, consider the Liver Cancer Fusion Predictor as your blood-based test for HCC screening.
Long-term heavy alcohol use can lead to cirrhosis, which significantly raises the risk of developing hepatocellular carcinoma even after stopping drinking. Long-term heavy alcohol use—even if you stopped drinking years ago—can significantly increase the risk of hepatocellular carcinoma (HCC). If you have a history of long-term heavy alcohol use, consider the Liver Cancer Fusion Predictor as your blood-based test for HCC screening.
Fatty liver disease is increasingly associated with liver cancer, particularly when it progresses to inflammation, fibrosis, or cirrhosis. If you have MASLD (formerly NAFLD), especially with obesity or type 2 diabetes, consider the Liver Cancer Fusion Predictor as your blood-based test for HCC screening.
Cirrhosis from any cause substantially increases the risk of hepatocellular carcinoma (HCC). If you have cirrhosis, regular HCC surveillance is important. Consider the Liver Cancer Fusion Predictor as your blood-based test for HCC screening every 6 months.
Having a close family member with liver cancer may increase your risk, particularly when combined with hepatitis B or other liver disease. If liver cancer runs in your family, consider the Liver Cancer Fusion Predictor as your blood-based test for HCC screening.
Type 2 diabetes, obesity, and metabolic syndrome are associated with an increased risk of liver cancer, especially when fatty liver disease is also present. If you have these metabolic risk factors, consider the Liver Cancer Fusion Predictor as your blood-based test for HCC screening.
Before Your Appointment
After you order the test, MoleculeDx ships a blood collection kit to your home. The kit contains the materials needed for your blood draw and sample shipment. A trained phlebotomist will come to your home to collect the blood using the MoleculeDx kit. No fasting is required.
The Home Visit
A trained phlebotomist comes to your home and draws your blood using the collection materials provided in the MoleculeDx kit. The blood draw typically takes only 5–10 minutes, similar to a routine blood test. After collection, the phlebotomist prepares and ships the sample to the MoleculeDx laboratory for analysis.
Your Sample
After your blood is collected, the phlebotomist packages the sample using the materials provided in the MoleculeDx kit and ships it to the MoleculeDx laboratory for analysis. Sample handling and shipping procedures are designed to preserve the integrity of the specimen during transport.
Your Results
Within 24 hours after your sample is received by the MoleculeDx laboratory, you will receive a secure digital report showing whether your Liver Cancer Fusion Predictor result is positive or negative. The report is reviewed by a pathologist. If your result is positive, follow up with your healthcare provider for appropriate clinical evaluation and diagnostic imaging.
Early-stage liver cancer may cause no symptoms. If you are at increased risk, take a proactive step toward screening with a simple blood test collected at your home.
Common questions about ordering, at-home blood collection, results, and the Liver Cancer Fusion Predictor.
Click “Book a Test,” enter your information, and complete your order online. After your order is confirmed, MoleculeDx ships a blood collection kit to your home and arranges for a trained phlebotomist to collect your blood at home. The phlebotomist then ships the collected sample to the MoleculeDx laboratory for analysis.
No. You can order the Liver Cancer Fusion Predictor directly without a doctor’s prescription. If your result is positive, you should discuss the result with your healthcare provider for appropriate clinical evaluation and diagnostic imaging.
A trained phlebotomist comes to your home and performs a standard blood draw using the collection materials provided in your MoleculeDx kit. The blood draw typically takes only 5–10 minutes and is similar to a routine blood test. After the blood draw, the phlebotomist handles the sample packaging and shipment—you do not need to ship the sample yourself.
The test requires a standard blood draw. Most people experience only brief, mild discomfort similar to a routine blood test. The blood draw typically takes 5–10 minutes and is performed in your home by a trained phlebotomist.
No special preparation or fasting is required for the Liver Cancer Fusion Predictor. You may eat, drink, and take your usual medications as normal before the blood draw. Please have your MoleculeDx blood collection kit available when the phlebotomist arrives.
You can view your Liver Cancer Fusion Predictor result by logging into your MoleculeDx account. A password-protected PDF report will also be sent to your registered email address. The report shows whether your result is positive or negative and is reviewed by a pathologist. You can download or share the report with your healthcare provider.
Yes. If you need to cancel or reschedule your at-home blood collection, please contact MoleculeDx at support@moleculedx.com as soon as possible. We will work with you to reschedule your blood collection or assist with your cancellation.
The Liver Cancer Fusion Predictor is currently offered as a self-pay test, and MoleculeDx does not bill insurance directly. You may contact your insurance company to ask whether reimbursement is available under your individual plan. Upon request, MoleculeDx can provide documentation of your test and payment for you to submit to your insurer.
Yes. Your personal and medical information is protected and handled in accordance with applicable health information privacy requirements. Access to your information and test results is restricted to authorized personnel. Your report is available through your secure MoleculeDx account, and a password-protected PDF report is also sent to your registered email address.
If you have questions about your Liver Cancer Fusion Predictor report, contact MoleculeDx at support@moleculedx.com. We can help explain the report and answer questions about the test. For medical evaluation and decisions about follow-up imaging or treatment, please discuss your results with your healthcare provider.
© 2026 MoleculeDx Inc. All rights reserved.
Test results should be interpreted in the context of other clinical information and are not a substitute for evaluation by a qualified healthcare provider.
